comparemela.com

Evan Ya Wen Yu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kineta Appoints Internationally-Renowned Clinical Immuno-oncology Experts to its Scientific Advisory Board

01.03.2023 - SEATTLE, March 01, 2023 (GLOBE NEWSWIRE) - Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on developing next-generation immunotherapies to address cancer immune resistance, announced today the appointment of Myriam . Seite 1

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.